701 hedge funds and large institutions have $13.1B invested in GSK in 2014 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 337 increasing their positions, 217 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

14% less capital invested

Capital invested by funds: $15.2B → $13.1B (-$2.11B)

22% less funds holding in top 10

Funds holding in top 10: 97 (-2)

31% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 58

Holders
701
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$210M
Puts
$145M
Net Calls
Net Calls Change

Top Buyers

1 +$269M
2 +$160M
3 +$146M
4
Macquarie Group
Macquarie Group
Australia
+$56.4M
5
Morgan Stanley
Morgan Stanley
New York
+$55.4M

Top Sellers

1 -$995M
2 -$315M
3 -$101M
4
Renaissance Technologies
Renaissance Technologies
New York
-$93.9M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$84.5M
Name Holding Trade Value Shares
Change
Change in
Stake
426
$593K
427
$584K
428
$580K
429
$576K
430
$564K
431
$558K
432
$553K
433
$552K
434
$548K
435
$542K
436
$541K
437
$540K
438
$531K
439
$527K
440
$526K
441
$525K
442
$522K
443
$511K
444
$510K
445
$509K
446
$507K
447
$507K
448
$506K
449
$506K
450
$499K